AssetMark’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CRMD
AssetMark's CRMD Position: Q3 2026 in Review
AssetMark opened a new position in CorMedix (CRMD) in Q3 2026: 22 shares worth $169. The stake represents ﹤0.01% of the portfolio and ranks #3636 among its holdings.
144 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.
- AssetMark held 22 shares of CorMedix worth $169 as of Q3 2026.
- CorMedix was a new AssetMark position in Q3 2026.
- CorMedix made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3636 holding.
- 144 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.